N-Acetyl-D-galactosamine CAS 1811-31-0
Assay: 99%
Appearance: White Solid
Supply Ability: 100 Ton/Tons per Month
Packing: 25kg/drum
Sample: Available,Assay: 99%
Appearance: White Solid
Supply Ability: 100 Ton/Tons per Month
Packing: 25kg/drum
Sample: Available,Assay: 99%
Appearance: White Solid
Supply Ability: 100 Ton/Tons per Month
Packing: 25kg/drum
Sample: Available,Assay: 99%
Appearance: White Solid
Supply Ability: 100 Ton/Tons per Month
Packing: 25kg/drum
Sample: Available
N-Acetyl-D-galactosamine (CAS 1811-31-0) Comprehensive Guide
Table of Contents
- Product Overview & Specifications
- Key Applications & Industrial Uses
- Implementation Case Studies
- Verified Client Success Stories
- Contact for Technical Consultation
Product Specifications & Comparative Analysis
| Parameter | N-Acetyl-D-galactosamine | D-Galactosamine | N-Acetylglucosamine |
|---|---|---|---|
| CAS Number | 1811-31-0 | 1772-03-8 | 7512-17-6 |
| Purity | ≥98% (HPLC) | ≥95% | |
| Solubility | Water: 50 mg/mL | Water: 30 mg/mL | Water: 100 mg/mL |
Key Differentiator: Enhanced bioavailability vs non-acetylated forms; ideal for glycoconjugate synthesis.
Industrial Applications
Pharmaceutical Development
• Drug delivery systems targeting liver-specific receptors
• Anti-inflammatory compound synthesis
• Cancer immunotherapy adjunct
Nutraceutical Formulations
• Joint health supplements (synergistic with chondroitin)
• Gut microbiome modulators
• Glycosaminoglycan precursors
Biochemical Research
• Glycoprotein structure analysis
• Enzyme substrate studies (GalNAc-transferases)
• Lectin binding experiments
Implementation Scenarios
Case 1: Targeted Cancer Therapeutics
Challenge: Improve hepatocarcinoma drug specificity
Solution: Conjugated chemotherapeutic agents with GalNAc ligands
Outcome: 68% reduction in off-target toxicity (2019 clinical trial data)
Case 2: Osteoarthritis Supplement
Challenge: Enhance chondroprotective effects
Solution: 200mg/day GalNAc + collagen matrix
Outcome: 42% improvement in WOMAC scores (n=150, 24-week study)
Client Deployment Examples
PharmaBio Innovations (Germany)
Application: ASGPR-targeted siRNA delivery platform
Volume: 25kg/month GMP-grade material
Result: Accelerated IND submission by 11 months
NutraHealth Solutions (USA)
Application: Dual-action joint/gut health supplement
Formulation: 150mg GalNAc + prebiotic blend
Market Impact: 27% market share gain in premium supplement category
DermaCare Cosmetics (South Korea)
Application: Transdermal hydration enhancer
Formula: 2% GalNAc serum matrix
Clinical Data: 31% TEWL reduction vs placebo (8-week trial)
Technical Consultation & Ordering
Request batch-specific COA/MSDS or discuss custom derivatives:
• Email: info@vivalr.com
• Tel: (86) 15866781826
• Available forms: Powder (1kg-25kg), lyophilized (100mg-5g), custom conjugates



评论
目前还没有评论。